Long-term efficacy of insulin pump therapy on glycemic control in adults with type 1 diabetes mellitus

Diabetes Technology and Therapeutics

Volumn 17, Issue 1, 2015, Pages 49-54

  Orr, Christine J ^a,b   Hopman, Wilma ^a   Yen, Joy L ^a   Houlden, Robyn L ^a,c  

^a QUEEN S UNIVERSITY   (Canada)

^b KINGSTON GENERAL HOSPITAL   (Canada)

^c NONE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; INSULIN; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTINUOUS SUBCUTANEOUS INSULIN INFUSION; CONTROLLED STUDY; DISEASE DURATION; FEMALE; FOLLOW UP; GLYCEMIC CONTROL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; INSULIN PUMP; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SMOKING; TREATMENT OUTCOME; ANALYSIS; BLOOD; CANADA; DIABETES MELLITUS, TYPE 1; DRUG EFFECTS; GLUCOSE BLOOD LEVEL; MIDDLE AGED; TIME; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BLOOD GLUCOSE; CHILD; DIABETES MELLITUS, TYPE 1; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN INFUSION SYSTEMS; MALE; MIDDLE AGED; ONTARIO; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84920836652     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2014.0131     Document Type: Article

References (14)

1. Selam JL: Evolution of diabetes insulin delivery devices. J Diabetes Sci Technol 2010;4:505-513.
2. Hoogma RP, Hammond PJ, Gomis R, et al.: Comparison of the effects of continuous subcutaneous insulin infusion (CSII) and NPH-based multiple daily insulin injections (MDI) on glycaemic control and quality of life: results of the 5-Nations Trial. Diabet Med 2005;23:141-147.
3. Miss ML, Egberts KJ, Page M, et al.: Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus. Cochrane Database Syst Rev 2010;1:CD005103.
4. Reznik Y, Morera J, Rod A, et al.: Efficacy of continuous subcutaneous insulin infusion in type 2 diabetes mellitus: a survey on a cohort of 102 patients with prolonged followup. Diabetes Technol Ther 2010;12:931-936.
5. Carlsson BM, Attvall S, Clements M, et al.: Insulin pumplong-term effects on glycemic control: an observational study at 10 diabetes clinics in Sweden. Diabetes Technol Ther 2013;15:302-307.
6. Jakisch BI, Wagner VM, Heidtmann B, et al.: Comparison of continuous subcutaneous insulin infusion (CSII) and multiple daily injections (MDI) in paediatric Type 1 diabetes: a multicentre matched-pair cohort analysis over 3 years. Diabet Med 2008;25:80-85.
7. Plotnick LP, Clark LM, Brancata FL, et al.: Safety and effectiveness of insulin pump therapy in children and adolescents with type 1 diabetes. Diabetes Care 2003;26: 1142-1146.
8. Batajoo RJ, Messina CR, Wilson TA: Long-term efficacy of insulin pump therapy in children with type 1 diabetes mellitus. J Clin Res Pediatr Endocrinol 2012;4:127-131.
9. Nimri R, Weintrob N, Benzaquen H, et al.: Insulin pump therapy in youth with type 1 diabetes: a retrospective paired study. Pediatrics 2006;117:2126-2131.
10. Weinzimer SA, Ahern JH, Doyle EA, et al.: Persistence of benefits of continuous subcutaneous insulin infusion in very young children with type 1 diabetes: a follow-up report. Pediatrics 2004;114:1601-1605.
11. Erratum in Pediatrics 2005; 115:518.
12. Nixon R, Folwel R, Pickup JC: Variations in the quality and sustainability of long-term glycaemic control with continuous subcutaneous insulin infusion. Diabet Med 2014; 21:1174-1177.
13. Grzanka M, Matejko B, Cyganek K, et al.: Efficacy and safety of insulin pump treatment in adult T1DM patients-influence of age and social environment. Ann Agric Environ Med 2012;19:573-575.
14. Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329:977-986.